Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial
Bipolar disorder is a chronic disorder characterized by a significant disease burden. While many agents effectively treat symptoms of mania, treatments for depressive episodes associated with bipolar disorder are limited. Lumateperone, a mechanistically